Dr. Furlow is an early-career thoracic surgeon-scientist whose observations in the operating room translate to his work characterizing the molecular mechanisms that drive lung cancer progression, metastasis, and post-resection recurrence. In close collaboration with Dr. Michael Yaffe’s lab at the Koch Institute, Dr. Furlow studies bidirectional signaling between lung cancer cells and the tumor immune microenvironment, with the goal of developing novel treatments for lung cancer.
Paul Furlow M.D Ph.D
Principal Investigator